Close Menu

In a paper published online in advance in Genome Research this week, researchers at the Weizmann Institute of Science report having reconstructed the content of the CRISPR bacterial immune system in the human gut microbiomes of 124 European individuals, and then having used that "to identify a catalogue of 991 phages targeted by CRISPR across all individuals," they write.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.